US Bancorp’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

US Bancorp’s Portfolio MORF Stock Details MORF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-998	Closed	-$34K	–	4219
2024 Q2	$34K	Hold	998	–	–	﹤0.01%	2848
2024 Q1	$35.1K	Hold	998	–	–	﹤0.01%	2866
2023 Q4	$28.8K	Buy	998 +980	+5,444%	+$23.3K	﹤0.01%	2908
2023 Q3	$412	Sell	18 -2,830	-99%	-$149K	﹤0.01%	3869
2023 Q2	$163K	Buy	+2,848	New	+$149K	﹤0.01%	1974
2022 Q2	–	Sell	-126	Closed	-$5K	–	4280
2022 Q1	$5K	Buy	+126	New	+$5.27K	﹤0.01%	3639
2021 Q4	–	Sell	-124	Closed	-$7K	–	4256
2021 Q3	$7K	Buy	+124	New	+$7.5K	﹤0.01%	3569

Other funds holding MORF

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Hoey Investments Coatesville, Pennsylvania $693M AUM 34.99% 1-Year Est. Return

US Bancorp's MORF Position: Q3 2024 in Review

US Bancorp sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 998 shares — an estimated $34K sold.

US Bancorp first reported a position in MORF in Q3 2021 and held it in 7 quarters. The position peaked at $163K in Q2 2023. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

US Bancorp reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
US Bancorp sold 998 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $34K.
US Bancorp first reported a position in Morphic Holding, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
US Bancorp's Morphic Holding, Inc. Common Stock position peaked at $163K in Q2 2023.
2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on US Bancorp's 13F filing for Q3 2024, filed 28 Oct 2024.